1. Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses. Issue 10 (16th August 2022) Authors: Han, Kelong; Theodore, Dickens; McMullen, Gina; Swayze, Eric; McCaleb, Michael; Billioud, Gaetan; Wieland, Stefan; Hood, Steve; Paff, Melanie; Bennett, C. Frank; Kwoh, T. Jesse Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 10(2022) Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗